Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Mark Jeng
Clinicogenomic analysis of EGFR -mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation
Editor’s summary Abstract Supplementary Materials REFERENCES AND NOTES Information & Authors Metrics & Citations Check Access References Figures Tables Media Share Editor’s summary Non–small cell lung cancer (NSCLC) can develop resistance to targeted therapy by transforming into small cell lung cancer (SCLC) or lung squamous cell carcinoma (LUSC). Here, Dymun et al.
Cancer type-specific variation in patterns of driver alterations across 50,000 tumors
|
Main text (Cancer Cell , 1–18, May 11, 2026) Due to a typesetting error, this article was initially published online with an incorrect Received date of March 4, 2025. The manuscript was originally submitted to on April 26, 2024, and subsequently transferred to on January 7, 2026. The Received date should have reflected the original submission date of April 26, 2024. The journal has now corrected the Received date online and apologizes to the authors and readers for the confusion.
By Chaitanya Bandlamudi, Daniel Muldoon, Ino de Bruijn, Mingxuan Zhang, Michael V. Gormally, Emily Harrold, Subhiksha Nandakumar, Shaleigh A. Smith, Mark Jeng, Sydney Woods, Kanika Arora, Walid K. Chatila, Bastien Nguyen, Henry Walch, Jun Woo, Craig M. Bielski, Christopher H Fong, Thinh Tran, Gaofei Zhao, Miika Mehine, Sam E. Tischfield, Allison Richards, Suraj Rajendran, Hongxin Zhang, Christoph K. Kreitzer, Ronak Shah, Risha Huq, Jesse Galle, Tina Alano, Ramyasree Madupuri, Ritika Kundra, Justin Jee, Karl Pichotta, Michele Waters, Richard A. Hickman, Josephine K. Dermawan, Jie-Fu Chen, Anton Safonov, Konrad H. Stopsack, Ritesh R. Kotecha, Hira Rizvi, Claire F. Friedman, Pedram Razavi, Ezra Y Rosen, Yonina R. Murciano-Goroff, Luc G.T. Morris, James A. Fagin, Ingo K. Mellinghoff, Ping Chi, Neerav Shukla, Adam Schoenfeld, Gregory J Riely, Charles M. Rudin, Alexander Drilon, Jake Lee, Hikmat Al-Ahmadie, Gopa Iyer, Anna Varghese, Eileen M. O’Reilly, Zsofia K. Stadler, Mark E. Robson, Ed Reznik, Jianjiong Gao, Diana Mandelker, Irina Ostrovnaya, Satshil Rana, Gowtham Jayakumaran, Anita S. Bowman, Abhinita S Mohanty, Anoop Rema Balakrishnan, Aijazuddin Syed, Ryan N. Ptashkin, Jacklyn Casanova-Murphy, Debyani Chakravarty, Ryma Benayed, Maria E. Arcila, Sarat Chandarlapaty, Helena A. Yu, Neal Rosen, Mark T.A. Donoghue, Christopher A Klebanoff, Rona Yaeger, A. Rose Brannon, Ahmet Zehir, Marc Ladanyi, Nikolaus Schultz, David B. Solit, Michael Berger Verified
|
Cell Press
Verified
Cancer type-specific variation in patterns of driver alterations across 50,000 tumors
|
Refers to: Keywords cancer type-specific tissue-specific driver alterations hotspots precision oncology clinical sequencing age of cancer diagnosis HLA genotype neoantigen-directed TCR therapies HLA loss of heterozygosity Introduction Cancer is a genetic disease defined by the serial acquisition of cell fitness-promoting mutations, referred to as “drivers.”1 Characterization of driver alterations is fundamental to understanding cancer pathogenesis, molecular classification of tumors, and...
By Chaitanya Bandlamudi, Daniel Muldoon, Ino de Bruijn, Mingxuan Zhang, Michael V. Gormally, Emily Harrold, Subhiksha Nandakumar, Shaleigh A. Smith, Mark Jeng, Sydney Woods, Kanika Arora, Walid K. Chatila, Bastien Nguyen, Henry Walch, Jun Woo, Craig M. Bielski, Christopher H Fong, Thinh Tran, Gaofei Zhao, Miika Mehine, Sam E. Tischfield, Allison Richards, Suraj Rajendran, Hongxin Zhang, Christoph K. Kreitzer, Ronak Shah, Risha Huq, Jesse Galle, Tina Alano, Ramyasree Madupuri, Ritika Kundra, Justin Jee, Karl Pichotta, Michele Waters, Richard A. Hickman, Josephine K. Dermawan, Jie-Fu Chen, Anton Safonov, Konrad H. Stopsack, Ritesh R. Kotecha, Hira Rizvi, Claire F. Friedman, Pedram Razavi, Ezra Y Rosen, Yonina R. Murciano-Goroff, Luc G.T. Morris, James A. Fagin, Ingo K. Mellinghoff, Ping Chi, Neerav Shukla, Adam Schoenfeld, Gregory J Riely, Charles M. Rudin, Alexander Drilon, Jake Lee, Hikmat Al-Ahmadie, Gopa Iyer, Anna Varghese, Eileen M. O'Reilly, Zsofia K. Stadler, Mark E. Robson, Ed Reznik, Jianjiong Gao, Diana Mandelker, Irina Ostrovnaya, Satshil Rana, Gowtham Jayakumaran, Anita S. Bowman, Abhinita S Mohanty, Anoop Rema Balakrishnan, Aijazuddin Syed, Ryan N. Ptashkin, Jacklyn Casanova-Murphy, Debyani Chakravarty, Ryma Benayed, Maria E. Arcila, Sarat Chandarlapaty, Helena A. Yu, Neal Rosen, Mark T.A. Donoghue, Christopher A Klebanoff, Rona Yaeger, A. Rose Brannon, Ahmet Zehir, Marc Ladanyi, Nikolaus Schultz, David B. Solit, Michael Berger Verified
|
Cell Press
Verified
Lack of disease control remains a major barrier to transplant for older patients with AML - Bone Marrow Transplantation
This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Rent or buy this article Get just this article for as long as you need it $39.95 Prices may be subject to local taxes which are calculated during checkout Additional access options: Log in Learn about institutional subscriptions Read our FAQs Contact customer support Data availability The datasets...
SMYD2-Mediated Histone Methylation Contributes to HIV-1 Latency
To use the Enhanced view of this article, please enable JavaScript on in your browser and refresh the page.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Mark
Contact Mark, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack